Home/ Products / Biosimilar Antibodies
DMS1029-100ug
100ug
$350
| note | Other commonly used names in publications refering to this antibody: MG-A271, MGA271 |
| target | CD276 / B7-H3 |
| alias | B7-H3, CD276, B7 homolog 3 |
| gene id | Uniprot ID: Q5ZPR3 |
| host species | Humanized |
| reactivity | Human |
| iso type | Human IgG1 kappa |
| formulation | Lyophilized from sterile PBS, pH 7.4. Typically, 5% - 8% trehalose is added as a protective agent prior to lyophilization. |
| reconstitution | Reconstitute lyophilized powder with water to a concentration of 100 ug/ml |
| applications | ELISA, Flow Cyt |
| dilution | ELISA 1:5000-10000; Flow Cyt 1:100 |
| shipping | Shipped at ambient conditions. |
| storage | Lyophilized form is stable for 1 week at room temperature. Store at -20 °C to -80 °C for 12 months in lyophilized form. After reconstitution, store at 4 °C for 2-7 days or at below -20 °C for up to 3 months. |
ELISA plate pre-coated by 2 ug/ml (100 ul/well) Human B7-H3, mFc-His tagged protein binds to Anti-B7-H3 Neutralizing antibody in a linear range of 0.24-31.25 ng/ml.
Flow cytometry analysis with 1ug/mL Anti-B7-H3 (enoblituzumab biosimilar) mAb on Hela cells (Blue histogram) or isotype control mAb on Hela cells (Red histogram).
Flow cytometry analysis of antigen binding of anti-human B7-H3 mAb. (A) A clear peak shift of The antibody was seen compared to the control when incubated with B7-H3-expressing Hela cells, indicating strong binding of The antibody to B7-H3. Antibodies were incubated at 2 ug/mL.
DMS1029-100ug
100ug
$350